BA
Bluesphere Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
1,550
+349
| +29% | +$272K | 0.6% | 27 |
|
|
2025
Q1 | $992K | Buy |
1,201
+28
| +2% | +$23.1K | 0.57% | 31 |
|
|
2024
Q4 | $905K | Buy |
1,173
+207
| +21% | +$160K | 0.44% | 34 |
|
|
2024
Q3 | $856K | Buy |
966
+16
| +2% | +$14.2K | 0.42% | 33 |
|
|
2024
Q2 | $860K | Sell |
950
-260
| -21% | -$235K | 0.44% | 32 |
|
|
2024
Q1 | $941K | Buy |
1,210
+1
| +0.1% | +$778 | 0.52% | 31 |
|
|
2023
Q4 | $705K | Buy |
1,209
+600
| +99% | +$350K | 0.44% | 34 |
|
|
2023
Q3 | $327K | Buy |
609
+1
| +0.2% | +$537 | 0.24% | 55 |
|
|
2023
Q2 | $285K | Buy |
608
+1
| +0.2% | +$469 | 0.2% | 65 |
|
|
2023
Q1 | $208K | Buy |
607
+2
| +0.3% | +$686 | 0.17% | 76 |
|
|
2022
Q4 | $221K | Buy |
+605
| New | +$221K | 0.2% | 77 |
|